Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04382404 · ClinicalTrials.gov registry record · Phase 1
Treatment of Chronic Hepatitis C During Pregnancy With Sofosbuvir/Velpatasvir
A Phase 1 study, sponsored by Catherine Anne Chappell.
- Completed
- Registry status
- Phase 1
- Development phase
- 11
- Enrollment target
NCT04382404 is a Phase 1 study that has completed, run by Catherine Anne Chappell. The registered enrollment target is 11 participants.
The verdict
NCT04382404, a Phase 1 study, has completed, sponsored by Catherine Anne Chappell.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
A single-arm, single-center, open label Phase 1 study of a 12-week course of Sofosbuvir (SOF)/Velpatasvir (VEL) in 10 HCV-infected pregnant women 1 that will evaluate the plasma pharmacokinetic parameters of SOF/VEL administered during pregnancy and compare them to those of a historical cohort of nonpregnant women.
Interventions
- DRUG Sofosbuvir-Velpatasvir Drug Combination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2020-10-22 |
| Est. Completion | 2023-10-16 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04382404
The ClinicalTrials.gov registry entry for NCT04382404 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Catherine Anne Chappell, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sofosbuvir-Velpatasvir Drug Combination is the first listed.
NCT04382404 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04382404 about?
NCT04382404 is a clinical study titled "Treatment of Chronic Hepatitis C During Pregnancy With Sofosbuvir/Velpatasvir". A single-arm, single-center, open label Phase 1 study of a 12-week course of Sofosbuvir (SOF)/Velpatasvir (VEL) in 10 HCV-infected pregnant women 1 that will evaluate the plasma pharmacokinetic parameters of SOF/VEL administered during pregnancy and compare them to those of a historical cohort of no...
What is the current status of trial NCT04382404?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 11 participants. The study started on 2020-10-22. Estimated completion is 2023-10-16.
What interventions are being tested in trial NCT04382404?
The interventions under investigation include: Sofosbuvir-Velpatasvir Drug Combination (DRUG).
Who is sponsoring clinical trial NCT04382404?
This trial is sponsored by Catherine Anne Chappell, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.